DiaMedica Therapeutics
Price & Volume
Stats
See more52W Range | $5.24-$10.41 |
Market Cap | $449.2M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.72 |
News
See moreYahoo Finance • last month
DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences
Yahoo Finance • 2 months ago
DiaMedica anticipates ReMEDy2 interim analysis in Q1 2027 as enrollment surpasses 85% of 200-patient trigger
Yahoo Finance • 2 months ago
DiaMedica Therapeutics (DMAC): BioTech with Breakthrough Potential
Yahoo Finance • 6 months ago
After-Hours Earnings Report for March 30, 2026 : PRGS, PHR, DMAC, AIRJ, SPCE, HQI, SGMO, RNXT, INLX, FTHM
About
CEO | Mr. Dietrich John Pauls MBA |
CFO | Mr. Scott Kellen CPA |
Address | 301 Carlson Parkway, Minneapolis, MN, United States, 55305 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 35 |